Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Inbiomotion logo — Perspective from knowledge

Inbiomotion

Perspective from knowledge

Founded 2010 Spain Spain 12 employees Venture round Total: $4.25M Biotechnology, Health Care +1

General Information

Company Name Inbiomotion
Founded Year 2010
Location Spain Spain
Founders / Decision Makers
Team member Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Inbiomotion. To contact Inbiomotion, visit inbiomotion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Inbiomotion compare?

A PDF of Inbiomotion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Inbiomotion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Inbiomotion

Inbiomotion is a biotechnology startup based in Spain, founded in 2010. The company's slogan, "Perspective from knowledge," reflects its commitment to providing objective insights into patients' MAF gene levels. Their test aims to empower pathologists and oncologists with vital information, enabling effective and efficient treatment with bisphosphonates while minimizing the risk of relapse. Their recent Venture Round investment on 21 January 2021 attracted the attention of Alta Life Sciences and ICF Capital, showcasing confidence in the company's potential. With a focus on driving clinical results, Inbiomotion aims to advance precision medicine and make a meaningful impact in the field of healthcare.

Business keywords: precision medicine, oncology, MAF gene, clinical testing, pathology, biomarker, cancer treatment, bisphosphonates, genetic testing, risk assessment, relapse prevention, clinical insights, medical innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Alta Life Sciences
Alta Life Sciences, ICF Capital
21 Jan 2021
Series B €2.20M 3
Caixa Capital Risc Ysios Capital
Caixa Capital Risc, Ysios Capital +1
13 Mar 2016
Grant €50.00K 1
EASME - EU Executive Agency for SMEs
01 Mar 2016
Series A €2.00M 1
Ysios Capital
Ysios Capital
28 Jun 2012

Inbiomotion Alternatives & Competitors

View All Alternatives
Inbiomotion vs
Antegenes
Antegenes Estonia

Innovative genetic tests for cancer risks with recommendations for prevention and early detection.

Seed
16 employees
Biotechnology, Health Care
Inbiomotion vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Inbiomotion vs
Madison Vaccines
Madison Vaccines

Developing innovative vaccines for prostate cancer patients and a test to determine their effectiven...

Venture round
Biotechnology, Health Care
View all alternatives

FAQ About Inbiomotion

Perspective from knowledge
Inbiomotion was founded in 2010.
Inbiomotion is headquartered in Spain.
Inbiomotion operates in Biotechnology, Health Care and Health and Wellness. Its work centres on precision medicine, oncology, MAF gene and clinical testing.
Inbiomotion has approximately 12 employees.
Inbiomotion has completed 4 funding rounds, raising a total of $4.25M. The latest funding stage is Venture round.
Top alternatives and competitors to Inbiomotion include Antegenes, OncoDNA, Madison Vaccines, Epitopea, CCG.ai (acquired by Dante Labs). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Inbiomotion and Antegenes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Inbiomotion, https://bouncewatch.com/company/inbiomotion, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes